US 10053503
Monoclonal antibodies that neutralize anthrax toxins
granted A61KA61K2039/505A61K51/1009
Quick answer
US patent 10053503 (Monoclonal antibodies that neutralize anthrax toxins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K51/1009, A61P, A61P31/04